![Cancer Network Podcasts show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/044/862/small/cancer-network-podcasts.png)
Summary: We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.
Summary: We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.